- Scientists stunned: New vaccine shows hope against deadliest breast cancer  The Times of India
- Breast Cancer: Triple-negative breast cancer vaccine shows promise in phase 1 clinical trial  The Times of India
- Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants  PR Newswire
- Cleveland Clinic Presents Final Results of Phase 1 Clinical Trial of Preventive Breast Cancer Vaccine Study | Newswise  Newswise
- Triple-negative breast cancer vaccine shows promise in early clinical trial  NBC News
​Scientists stunned: New vaccine shows hope against deadliest breast cancer  The Times of IndiaBreast Cancer: Triple-negative breast cancer vaccine shows promise in phase 1 clinical trial  The Times of IndiaAnixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants  PR NewswireCleveland Clinic Presents Final Results of Phase 1 Clinical Trial of Preventive Breast Cancer Vaccine Study | Newswise  NewswiseTriple-negative breast cancer vaccine shows promise in early clinical trial  NBC News by Soban News (international And National News)
